Mice Model Market: Current Analysis and Forecast (2022-2030)

Mice models, known as genetically modified mice, are living organisms that have been genetically modified to exhibit specific characteristics that mimic human diseases. These models are widely used in medical research to study mechanisms of diseases, test potential therapies, and develop new treatments. Mice models play a crucial role in drug discovery and help researchers to better understand disease pathways that are safe and effective for humans. There are several growth factors that will drive the market such as the increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular diseases. Mice models provide researchers with a way to study these complex diseases and develop new treatments. For instance, as per American Heart Association (AHA), coronary heart disease causes 1 in every 7 deaths in the U.S., resulting in about 366,800 deaths each year. In addition, in 2020, there were 2.2 million new cases of lung cancer reported.

The mice model market is expected to grow at a steady rate of around 8% owing to the advancement of genetic engineering technologies has led to the development of more accurate and precise mice models, enabling researchers to better mimic human diseases and test potential therapies. Major companies in the market are working on product advancement and research activities which is beneficial for the growth of this market. For instance, in Europe, Taconic Biosciences began producing humanized immune system mouse models in February 2020. This extended the organization's assembling limit as well as its client base in Europe.

Based on mice type, the market is segmented into inbred, outbred, knockout, hybrid, and others. Amongst them, the inbred category is to witness higher CAGR during the forecast period owing to the inbred model type being expected to dominate the market due to its stable genetic makeup and reproducibility. The knockout model type is also expected to grow significantly due to its ability to mimic human diseases and study gene function.

On the basis of technology, the market is categorized into CRISPR, microinjection, embryonic stem cell injection, nuclear transfer, and others. Among these, the CRISPR/Cas9 technology is expected to hold the largest share of the market due to its high precision and efficiency in gene editing. The embryonic stem cell injection technology is also expected to grow significantly due to its ability to generate genetically modified mice models.

Based on application, the mice model market has been classified into drug discovery & development, research centers, and pdx models/xenograft. The drug discovery & development category is to witness higher adoption of the mice model during the forecast period. The mice model market is closely linked to the drug discovery and development process, as mice models are widely used in preclinical studies to test potential therapies and understand drug mechanisms of action. Mice models provide a platform to study human diseases and understand disease mechanisms, which is critical for the development of new treatments.

Based on end-user, the mice model market has been classified into academics institute & research centers, pharmaceutical & biotech companies, CROs and CMOs, and others. The academic and research institutions category held the largest share of the market in 2021 owing to the increasing demand for mice models in academic research. Mice models provide a platform to study human diseases and understand disease mechanisms. Additionally, mice models are used to develop new treatments for a variety of diseases, including cancer, cardiovascular diseases, and neurological disorders.

For a better understanding of the market adoption of the mice model industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America is expected to hold the largest share of the mice model market due to the presence of leading biotechnology and pharmaceutical companies and academic research institutions in the region. The increasing demand for mice models in drug development and the growing prevalence of chronic diseases, such as cancer and cardiovascular diseases, are driving market growth. For instance, according to the data published by the American Cancer Society (ACS), in January 2020, around 1.8 million new cancer cases were diagnosed and 606,520 cancer deaths in the United States.

Some of the major players operating in the market include: Envigo Marketing Private Limited; Laboratory Corporation of America® Holdings; Janvier Labs; Harbour Antibodies Bv; Charles River Laboratories; THE JACKSON LABORATORY; Taconic Biosciences, Inc.; genOway; Horizon Discovery Ltd., Company; and ingenious targeting laboratory